Identification of a sequential B-cell epitope on major allergen (Cry j 1) of Japanese cedar (Cryptomeria japonica) pollen in mice

被引:12
|
作者
Tamura, Y
Sasaki, R
Inouye, S
Kawaguchi, J
Serizawa, N
Toda, M
Takemori, T
Sakaguchi, M
机构
[1] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan
[2] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, Tokyo 1628640, Japan
[3] Sankyo Co, Biomed Res Labs, Tokyo, Japan
关键词
B cell epitope; mice; pollen; allergen;
D O I
10.1159/000024448
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Japanese cedar (Cryptomeria japonica; CJ) pollinosis is one of the most common allergic diseases in Japan. B cell epitopes on Cry j 1, a major allergen of CJ pollen, have been analyzed by the specific monoclonal antibodies to Cry j 1, and most of these epitopes may be conformational, but no previous report has addressed the analysis of sequential epitope mapping with synthetic peptides, The main purpose of the present study is to identify IgE and IgG B cell epitopes on Cry j 1 by using a synthetic peptide approach in mice. Methods: We synthesized 35 overlapping peptides that cover the entire length of Cry j 1 and examined whether mouse IgE and IgG antibodies produced by immunization with Cry j 1 reacted to the Cry j 1 peptides. Results and Conclusion: We found that mouse IgE and IgG antibodies reacted strongly to Cry j 1 peptide No. 15 ((141)GVEPVHPQDGDALTLRTATN(160)), though those antibodies did not react with other peptides, IgE and IgG antibody binding to peptide No. 15 was completely inhibited by Cry j 1 and the peptide. To determine the minimum epitope in peptide No. 15, we conducted an ELISA inhibition test. IgE and IgG antibody binding to peptide No. 15 was inhibited by smaller peptides of this peptide. We found the core of the epitope to be (145)VHPQDGDA(152). Copyright (C) 2000 S.Karger AG, Basel.
引用
收藏
页码:228 / 235
页数:8
相关论文
共 27 条
  • [21] Specific B-cell Epitope of Per a 1: A Major Allergen of American Cockroach (Periplaneta americana) and Anatomical Localization
    Sookrung, Nitat
    Khetsuphan, Thanyathon
    Chaisri, Urai
    Indrawattana, Nitaya
    Reamtong, Onrapak
    Chaicumpa, Wanpen
    Tungtrongchitr, Anchalee
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2014, 6 (04) : 325 - 332
  • [22] Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific fab
    Padavattan, Sivaraman
    Schirmer, Tilman
    Schmidt, Margit
    Akdis, Cezmi
    Valenta, Rudolf
    Mittermann, Irene
    Soldatova, Lyudmila
    Slater, Jay
    Mueller, Ulrich
    Markovic-Housley, Zora
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 368 (03) : 742 - 752
  • [23] Identification of the Dominant T-Cell Epitopes of Lit v 1 Shrimp Major Allergen and Their Functional Overlap with Known B-Cell Epitopes
    Xu, Li Li
    Gasset, Maria
    Lin, Hong
    Yu, Chuang
    Zhao, Jin Long
    Dang, Xue Wen
    Li, Zhen Xing
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2021, 69 (26) : 7420 - 7428
  • [24] Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies
    Ti, Jinfeng
    Li, Zhijie
    Li, Xiuli
    Lu, Yunjian
    Diao, Youxiang
    Li, Fang
    PLOS ONE, 2017, 12 (07):
  • [25] Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing
    Theisen, M
    Soe, S
    Jessing, SG
    Okkels, LM
    Danielsen, S
    Oeuvray, C
    Druilhe, P
    Jepsen, S
    VACCINE, 2000, 19 (2-3) : 204 - 212
  • [26] Identification of B-cell epitopes on structural proteins VP1 and VP2 of Senecavirus A and development of a multi-epitope recombinant protein vaccine
    Zhang, Zhongwang
    Yao, Fei
    Lv, Jianliang
    Ding, Yaozhong
    Liu, Xinsheng
    Zhang, Liping
    Ma, Zhongyuan
    Zhou, Peng
    Wang, Yonglu
    Guo, Huichen
    Pan, Li
    VIROLOGY, 2023, 582 : 48 - 56
  • [27] A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx)
    Guo, Linlin
    Overholser, Jay
    Darby, Heather
    Ede, Nicholas J.
    Kaumaya, Pravin T. P.
    ONCOIMMUNOLOGY, 2022, 11 (01):